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ABSTRACT
Recent studies on methods of detecting the early onset of arthritic cartilage degradation using
NMR-based techniques have shown that such detection is possible. The use of sodium NMR
observations, along with an ideal Donnan single compartment model of cartilage, has already
been validated as a means of measuring cartilage fixed charge density - a known indicator of
cartilage condition. Similar calculations of fixed charge density from proton (in the presence of
gadopentetate) NMR observations and the same model were highly correlated with, but 50%
below, values derived from sodium NMR. Maroudas had previously shown the water content of
cartilage to be divided with a roughly 30:70 ratio between two physiologically distinct regions.
The first of these regions, within cartilage collagen fibrils, is electroneutral, with most of the
tissue fixed charge, in the form of chondroitin sulfate, being concentrated in the remainder of the
tissue, the second region. The existence of two compartments, with different associated fixed
charge densities, is shown, by spreadsheet computations and analysis of previously published
data, to be a possible reason for the observed 50% discrepancy. High-concentration chondroitin
sulfate solutions within dialysis tubing bags were equilibrated in solutions containing sodium and
gadopentetate ions. This solution/tubing apparatus mimicked an ideal Donnan single
compartment. MR measurements of the amounts of the two ions and calculations of fixed charge
density in the solutions based on the measurements yielded the same 50% factor. Since this
artificial model did not include any collagen, there were no compartmentalization effects due to
structural factors. A similar single-compartment was done using a non-ionic contrast agent to test
for steric exclusion based compartmentalization. Although MR measurements revealed a
discrepancy in contrast agent distribution, the discrepancy was exactly opposite what should have
been observed had steric exclusion been a factor. In summary, it seemed clear that
compartmentalization of water (from either cartilage structure or from steric exclusion) was not
primarily responsible for the observed 50% discrepancy. Another explanation must be found.
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Chapter 1: Introduction
Articular cartilage is a connective tissue found covering the surfaces of the bones
in a joint. It provides a lubricated surface to permit smooth motion, and serves to
harmlessly transfer load across the joint. Osteoarthritis is a degenerative disease of
cartilage progressing from inflammation to eventual destruction of the tissue. It affects
millions of people around the world. The United States, in particular, has cause for
concern as the baby-boom generation reaches the age groups found to be most affected
by arthritis. A 1992 study [77] (based on U.S. data collected between 1970 and 1987)
showed that over 55% of those over 70 years of age were afflicted with arthritis. This
makes the disease the number one concern for the elderly. The same study showed,
however, that the elderly are not the only ones affected by this disease.
Although arthritis only affects a mere 5% of the working age adults - those
between 18 and 64 years of age - the percentages shield the actual impact of disease. In
fact, over 9 million of the working age adults in the United States reported having
arthritis, and 5.5 million found their activities limited by the disease. The study
continued on to show that arthritis had an obvious detrimental effect on the labor
participation rate of those afflicted.
Clearly, arthritis is a disease with great relevance to the concerns of the nation
and, indeed, to the individuals of that nation. It is also a disease that is currently not well
understood. Preventive methods are primarily focused on eliminating risk factors derived
from an understanding of the function of cartilage at a mechanical rather than a molecular
level [64]. Current methods of diagnosis are based very much on reports of subjective
symptoms such as stiffness, swelling, fatigue, tenderness, pain, etc. A generally accepted
quantitative method for identifying the disease has yet to be established. Visualization
procedures for arthritis suffer from similar problems. Historically, visualization was via
radiographs, which permitted only an indirect and clumsy assessment of cartilage
condition by examining the space between the bones at a joint. More recently,
arthography and computed tomography permitted better visualization, but even these
invasive techniques were unable to identify arthritis prior to the appearance of gross
structural changes.
Magnetic resonance imaging (MRI), a visualization technique developed from
nuclear magnetic resonance (NMR), is an even more recent arrival in the visualization
field. It has met with considerable success imaging cartilage as several techniques now
exist to enhance the MRI contrast between different types of tissue. (The delineation
between the hard - bone - and soft - cartilage - tissues of joints is particularly good.)
Work has even been done to show that changes in cartilage thickness can be visualized
using MRI, permitting replacement of the more traditional radiographic images [63].
Recent efforts have focused using NMR and MRI as non-invasive tools to
quantitatively diagnose arthritis by attempting to detect pathologic indications of the
disease state. One of the early signs of osteoarthritis, is the loss of one type of material,
proteoglycan, from the tissue. Venn and Maroudas [72] showed that arthritic cartilage
shows a significant reduction in proteoglycans as compared to normal cartilage. A means
of measuring the proteoglycan content of cartilage, therefore, would provide a direct
measure of tissue health. MR methods for diagnosing arthritis have focused on just such
early detection of changes in cartilage proteoglycan content by making use of specific
properties of the compound. Lesperance et al [47] showed that NMR measurements of
sodium content of in vitro samples can lead to a quantitative determination of
proteoglycan content. Bashir et al's work [7] made use of the same principles to
demonstrate that proton NMR in the presence of a specific MR contrast agent,
gadopentetate dimeglumine, could be used for the same purpose. Recent work has further
established that MRI in the presence of gadopentetate dimeglumine can distinguish
arthritic cartilage from healthy human tissue and has suggested that in vivo monitoring of
proteoglycan is possible [5,6].
Strangely, although the technique established by Bashir et al succeeds in tracking
proteoglycan content, simultaneous measurements with sodium NMR and proton NMR
yield quantitative values that differ by roughly a factor of two [7]. The goal of this work
is to explore one hypothesis explaining the nature of this factor.
Chapter 2: Essential Background
2.1 Cartilage Physiology
There are many different cartilaginous tissues in the body. Nevertheless, all
forms of cartilage share a gross similarity in their composition. Cartilage is a mostly cell-
free tissue. The endogenous cells, known as chondrocytes, take up only about three to
five percent of the tissue volume. They do not take an active role in the biomechanical
role that cartilage plays but maintain, via synthesis, secretion, and degradation, an
extracellular matrix (ECM) to fill that role [31]. The ECM provides mechanical strength
via two main routes - electrical interactions due to ionic groups, and mechanical
interaction due to chemical bonds between the structural elements of the matrix [19].
This extracellular matrix, the main part of cartilage tissue, is made up of water
(65-80% of wet weight), collagen (15-25%), proteoglycans (3-10%), and various other
noncollagenous proteins and glycoproteins [51]. Considering the relatively low
concentration of noncollagenous proteins and glycoproteins present, cartilage can, for
some purposes, be considered primarily a two-phase mixture of porous but insoluble
collagen fibers and a solution of water and proteoglycans [19]. Figure 2.1 is a cartoon
sketch of a segment of cartilage incorporating the two main non-water components,
collagen and proteoglycan. These two elements will be the focus of the remainder of this
section.
The collagen building block is a triple helix of procollagen chains, which link to
each other via disulfide bonds during synthesis. The resulting collagen monomers,
molecules about 300nm long, are arranged into arrays in which individual monomers
again cross-link, forming microfibrillar bundles (Figure 2.2). Assembly continues as
bundles link to each other, leading eventually to the formation of a mature collagen fibril.
The final strand can be quite long (as much as I4m) and can have a diameter ranging
from 50 to 150nm depending on location [71]. This cross-linked collagen network
provides the structural support upon which the ECM is built. It provides tensile strength,
and limits swelling of the tissue from osmotic or hydrostatic pressures.
It is useful to note that although collagen molecules have chemical groups which
ionize at physiological pH, those which are positively charged (amino, NH 3 ) are about
equal in number to those which have a negative charge (carboxyl, COO-). As a result,
there is no net charge. This fact permits us to conclude below that collagen does not
contribute to our MR measurements.
The other major non-water constituent of cartilage is the proteoglycans. The
bottlebrush-like proteoglycans are usually found in large aggregates non-covalently inked
to hyaluronic acid chains. The binding of proteoglycan to acid is a complex process
requiring a linking protein to join the binding region of the proteoglycan protein core to
the acid. A proteoglycan is composed, as the name suggests, of a long protein core chain
to which are attached other sugar compounds known as glycosaminoglycans (GAGs). In
articular cartilage, these sugar compounds include disaccharide polymers, principally
keratan sulfate (KS) and chondroitin sulfate (CS).
Figure 2.2: Collagen in the extracellular matrix. Three procollagen strands twine to
form a triple helix, which cross-links with other similar strands to form a
microfibrillar bundle. The microfibrillar bundles then undergo further cross-
linking with other bundles to form higher order structures (larger fibrils and
fibers).
Figure 2.3 shows a cartoon of one proteoglycan. A proteoglycan strand is known
to have at least three different regions along the protein core [33]. One of these regions is
particularly rich in bound keratin sulfate, while the other is rich in bound chondroitin
sulfate. In general, the chondroitin sulfate is more plentiful not only because the CS
polymers tend to be longer than the KS polymers, but also because the CS binding region
is significantly larger, resulting in many more bound CS chains.
)Keratan Sulfate
i/
Binding Region
Core Protein
Chondroitin Sulfate
Figure 2.3: Cartoon of a proteoglycan molecule, the other major component of the
cartilage extracellular matrix, marking the core protein and three distinct regions.
For the purposes of this work, the focus will be primarily on the last region, the
chondroitin sulfate, which is the main charge carrying material. Not shown here
are the hyaluronic acid chains to which proteoglycans are bound, and the link
proteins, which connect the binding region to the acid.
A structural diagram of the chondroitin sulfate monomer in both its neutral and
ionized form is provided in Figure 2.4. At physiological pH, the disaccharide is ionized
with both the carboxyl (COO-) and sulfate (S03-) groups negatively charged. Each
Figure 2.4: The structural diagram of the chondroitin sulfate monomer is shown
here. At physiological pH, the monomer (MW = 459.39 g/mol) is ionized, with both
the carboxyl and the sulfate groups maintaining a negative charge.
disaccharide, therefore, has a net -2 charge. Unlike unbound ions in the electrolytic fluid,
which are free to diffuse in and out of the tissue, the charge on the chondroitin sulfate is
a
/
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firmly "fixed" to the proteoglycans in the cartilage. As a result, the tissue is said to
possess a fixed charge. In general, the concentration of fixed charge is referred to as the
fixed charge density - FCD. (Although keratan sulfate has not been described
specifically, it too is negatively charged at physiological pH - though only with a -1
charge per disaccharide [12] - contributing a component to the fixed charge density of
cartilage.) The proteoglycans, because of their charge, become responsible for much of
the stiffness and resilience of cartilage.
2.2 Donnan Based Derivation of FCD
The association of fixed charge with the proteoglycans on cartilage suggests that
accurate determination of fixed charge density might act as a useful measure of the
amount of proteoglycan in the tissue. (As has been noted previously, loss of
proteoglycans is one of the early signs of the onset of arthritis.) One method of
determining FCD, to be described here, makes use of measurements of mobile ion
concentrations.
The presence of the fixed charge within the cartilage attracts mobile ions of
opposite charge (counter-ions) and repels mobile ions of similar charge (co-ions).
Therefore, although the tissue as a whole - solid and fluid components - has no net
charge, an unequal distribution of mobile ions is set up between the tissue fluid and the
external solution - which has no fixed charge. Since positive cations are preferentially
attracted to the tissue while negative anions are repelled, the buildup of mobile charges
sets up an electrical potential (the Donnan electrical potential) across the interface of the
external solution and the cartilage. Distribution of ions obeys the Donnan equilibrium
equation [51], which relates ion concentrations to the Donnan potential.
The ideal Donnan assumption states that electrolyte activity coefficients for ions
are the same both in external solution and within any charged material, or, equivalently,
that the ratio of electrolyte activities in external solution to electrolyte activities in
charged material is equal to the ration of concentrations. This assumption, combined
with some other approximations [30], leads to the following general expression:
Le RT
SCi )
Equation 2.1
where
Ci concentration of species i in charged material
Ci = concentration of species i in external solution
Zi = charge on species i
T temperature
A1 Donnan potential
F Faraday's constant
R ideal gas constant
This relationship tells us that, at equilibrium, which implies no net flux of ions,
given a constant temperature, the ratio of concentrations of any species of ion within and
without a charged material is fixed to a constant value.
Another useful generalization deals with bulk electroneutrality. On a
macroscopic scale, any given volume must satisfy electroneutrality, the sum of all the
positive and negative charges within the volume must be zero. The following equations
express this statement for two regions; the interior of a charged material, and the external
solution.
ZCi+FCD = 0
Equation 2.2
SZi Ci = 0
Equation 2.3
Given these relationships, consider a sample of cartilage equilibrated in a solution
with a relatively high concentration of NaCl (Na+ and Cl), and much smaller
concentrations of other minor ions (PO-3 , CO -3 , H+, Gd-DTPA-2). Applying Equation 2.1
to some of the ions results in the expression below.
CNa+ C CI- C Gd-DTPA-2
CNa+ CCI- Gd-DTPA-2
Equation 2.4
This expression could be further extended to incorporate all the other ions present
as well. The Gd-DTPA -2 ion was chosen here as an example for reasons that will become
clear later in this work.
Application of Equation 2.2 and Equation 2.3 requires a little more thought. In
general, it is difficult to be absolutely sure exactly which ions are present in solution.
Certainly, the external solution surrounding cartilage in vivo contains a whole melange of
ions which differ to some extent depending on the individual in question. A key
approximation, however, makes these two equations simpler. The choice is to
approximate as equal to zero the concentrations of those ions which are present only at
relatively low concentrations. In the human body, most fluids contain relatively large
concentrations of NaCI, and a few other ions. The majority of the ions found are present
only at very low concentrations. For the example described above, Equation 2.2 and
Equation 2.3 simplify to the following:
CNa+ + cci- + FCD = 0
Equation 2.5
CNa+ + CcI_ =0
Equation 2.6
Note that here, only the Na and C1- ion need be considered, as all other ions are
only present at relatively low concentrations.
Putting together Equation 2.4, Equation 2.5 and Equation 2.6, we can solve for
fixed charge density in terms of the concentrations of various ions [7,47].
2 2
CCT CCr Cd-DTPA-2 Gd-DTPA 2
F C C -2 Cc - = NFCD- c a- + _ U CC1 = 
Gd-7DTPA d- -2
Na+ cI Gd-DTPA 2  Gd-DTPA
Equation 2.7
Some method of measuring ion concentrations, therefore, could lead directly to a
value for FCD. (Note, however, that measurements of anion concentrations are much
more likely to lead to errors in the values calculated for FCD. Since anions are
preferentially repelled from the negatively charged material, the actual concentrations
present are quite low. A fixed magnitude measurement error, therefore, will correspond
to a greater relative error for anions than for cations.) In the work described here, ion
concentrations are measured using NMR, and these measured values used to evaluate
fixed charge density.
2.3 Nuclear Magnetic Resonance (NMR)
The magnetic resonance techniques used for the various measurements in this
work have all been adequately described in the literature [7,22,23,47]. Nevertheless, a
certain minimum exploration of some of the fundamental ideas behind NMR is called for
at this point. An excellent quick reference (with very helpful graphics) for understanding
the basics of NMR physics, can be found on the world wide web on the Sheffield Hallam
University School of Science and Mathematics web server [1]. Another slightly more
detailed and ornate, but perhaps more useful web reference can be found at
http://www.cis.rit.edu/htbooks/nmr [38]. Useful sources for more general information
about NMR and MRI physics include particularly: Foundations of Medical Imaging by
Cho, Jones and Shing [18], An Introduction to Magnetic Resonance by Carrington and
McLachlan [17] and Magnetic Resonance Imaging edited by Partain. Finally, a very
cogent overview of the mathematics behind MRI and NMR can be found in papers by
Hinshaw et al [35], Sebastiani et al [70] and Mezrich [57].
2.3.1 Basic Principles
Atomic nuclei which contain an odd number of protons and/or neutrons possess a
net magnetic moment t. These nuclei also possess angular velocity J related to the
magnetic moment by Equation 2.8.
R=yJ
Equation 2.8
y is the gyromagnetic ratio, a fundamental nuclear constant that differs for every
atomic element. In the absence of external magnetic fields, the magnetic moments are
randomly oriented in space, and their vector sum is equal to zero. However, application
of a magnetic field B results in a torque applied to the nucleus. Because the nucleus also
has an angular momentum, J, the resulting motion is represented by:
dJ
Equation 2.9
Equation 2.9 simply states that the rate of change of angular momentum is
determined by the applied torque. Joining this equation to Equation 2.8, gives the
following interesting expression:
dt =y(gxB)
Equation 2.10
The magnetic moment changes in a direction perpendicular both to its direction
and to the applied static magnetic field. Like a spinning top in a gravitational field, the
magnetic moment begins to precess, as shown in Figure 2.5, around an axis parallel to the
static field.
Applied magnetic field
Precessional
orbit
Spinning
nucleus
Figure 2.5: Spinning nucleus and associated magnetic moment. When a magnetic
field is applied, the magnetic moment of the nucleus begins to precess about an axis
parallel to the applied field.
The frequency of precession (o in radians and f in Hertz), sometimes called the
Larmor frequency, can be determined by solving Equation 2.10.
= 2f = y I B I
Equation 2.11
Quantum mechanics requires, in the presence of a static magnetic field Bo, that a
particle with a magnetic moment be in one of a finite number of energy levels. The
actual number of energy levels is determined by the spin quantum number I, another
intrinsic characteristic of the nucleus in question. The energies associated with each level
are also a function of the spin and the magnetic field.
yhllBo hlooE , -I = h l fo2 2 =hfo
Equation 2.12
Note that the energy needed to move from one energy level to another is exactly
the amount of energy stored in a photon at the Larmor frequency, hfo.
The number of nuclei populating each energy level is determined by Boltzmann
statistics (Equation 2.13). At room temperature, although the thermal excitation is
sufficient to keep the population levels just about equal, there is a slightly larger number
of nuclei, some constant proportion of the total population, at the lower energy levels.
NH -AE/kT
NL
Equation 2.13
NH= number of nuclei at higher energy level
NL, number of nuclei at lower energy level
AE ~-difference in energy between energy levels
T - temperature
k Boltzmann's constant
For a system with only two energy levels (1H), Figure 2.6 depicts the arrangement
of the nuclei both before and after a static magnetic field is applied. The excess magnetic
moments in the lower energy level with its associated orientation of spins leads to the
formation of a net magnetization M along the direction of the static magnetic field Bo.
Magnetic resonance occurs when a radio frequency (RF) rotating magnetic field
B1, applied at the Larmor frequency causes magnetic moments to flip between energy
states. As Equation 2.12 showed, any photons at the Larmor frequency have the correct
amount of energy to cause switching between levels. Since, at equilibrium as just shown,
there is an excess of spins in the lower energy state, absorption of energy takes place as
spins are promoted to the higher energy levels. The RF pulse also serves to bring the
phases of the individual magnetic moments into a coherent relationship. From a
macroscopic perspective, this leads to the net magnetization vector M rotating away from
its equilibrium state and precessing about the direction of B1 with a frequency o given
by Equation 2.11. The direction of M is given in terms of the flip angle 0 = olt where t
is the duration of the B1 pulse.
(a) (b)
Figure 2.6: Nuclei before and after a static magnetic field Bo is applied. (a) depicts
the random arrangement of the magnetic moments before application of the field.
(b) shows the Bo field, and the resulting ordering of the magnetic moments into two
groups, with one set pointing up (parallel spin) and the other pointing down (anti-
parallel). The slight preponderance of those pointing up over those pointing down
cause the generation of a cumulative magnetic moment M.
Figure 2.7 depicts the state of the net magnetization immediately after the B1 field
is turned off. The deflected M continues to precess about the main Bo field as it slowly
returns to equilibrium. The component of M in the transverse plane, M,y, acts to induce
a current in a coil. The resulting exponentially decaying sinusoidal voltage is commonly
referred to as free induction decay (FID). The FID constitutes the MR signal.
When more than one species of atom is involved, each type rotates at a different
frequency, fo, changing the shape of the FID by contributing a component at the new
frequency.
Mxy
Figure 2.7: Depicted here is the state of net magnetization immediately after the
excitation pulse, B1, is turned off. M has been rotated away from the z-axis by an
angle 0. Under the influence of the static magnetic field, it continues to precess
about the z-axis which is collinear with the direction of Bo. This precession is
reflected in the xy plane by the rotation of the transverse component of M, Mxy.
2.3.2 Signal Intensity
The magnitude of the FID corresponds directly to the magnitude of Mxy.
Immediately after the B1 pulse is switch off, the magnitude of Mxy is directly related, via
the flip angle 0, to the magnitude of the net magnetization M.
I Mxy I = I M I sin 0
Equation 2.14
The magnitude of M, in turn, is directly related to the total number of nuclei. By
measuring the initial magnitude of the FID, therefore, and given some standards against
which to compare, it is possible to determine the total number of nuclei present. Further,
according to Fourier theory, the area under the curve of the Fourier transform of a signal
is equal to the initial magnitude of the FID. This means that a measure of the area under
the Fourier transform of the FID can also serve as a measure of the number of nuclei
present.
Measurements of nuclei-number via measurements of FID signal intensity can
also be performed regardless of the number of different atomic elements that are present.
Since y is different for every element, at a given static field strength B0, each element
responds to a different excitation frequency. Only that portion of the total net
magnetization due to the material of interest will respond to excitation at that frequency.
Measurement of the FID, therefore, can theoretically be used to pick out the amounts of
all magnetically active elements.
2.3.3 Relevant Time Constants
After excitation, the net magnetization vector M slowly returns toward its
equilibrium state via a process called relaxation. Relaxation is characterized by two time
constants T1 and T2. (Figure 2.9 and Figure 2.8.) These time constants depend on certain
chemical and physical characteristics of the nuclei of interest, as well as on the properties
of neighboring nuclei (which may consist of other elements). Measurements of
differences in these time constants, therefore, can contribute useful information about
elements other than those being directly excited by the RF radiation.
The spin-spin relaxation time, T2, is the characteristic time associated with
transverse magnetization relaxation. T2 is quite important as it determines the amount of
time available for stimulating and recording the FID. Equation 2.15, sketched in Figure
2.8, shows the relationship between T2 and the transverse component (My)of the net
magnetization M.
Mx =Md e
Equation 2.15
The spin-lattice relaxation time, TI, is the characteristic time associated with the
regeneration of longitudinal magnetization, the z-component of M. Equation 2.16,
sketched in Figure 2.9, shows the relationship between TI, and the longitudinal
magnetization.
M =Mo 1-e
Equation 2.16
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Figure 2.9: The spin-lattice relaxation time is associated with the renewal of the
longitudinal component of the net magnetization vector. Here, Mo represents the
magnitude of the net magnetization M at equilibrium (before any excitation has
taken place, or after the decay processes have been long completed).
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Figure 2.8: The spin-spin relaxation time describes the rate at which
magnetization, the detectable component of total magnetization, decays.
initial (detectable) transverse magnetization immediately after excitation.
transverse
Md is the
Interestingly, because of the physical process that cause relaxation, T2 is always
less than T 1. This has the practical consequence of requiring a minimum recovery time
between excitations since the transverse magnetization will have vanished below the
noise level before longitudinal magnetization has completely recovered.
Measurements of T1 are often made with what is known as an inversion recovery
sequence. The flip angle 0 is initially chosen to be 1800 rather than the more usual 900.
Once M is flipped by 1800, it has no transverse component. Recovery of the signal,
sketched in Figure 2.10, proceeds as described by Equation 2.17.
M = Mo- 2eT
Equation 2.17
M0 --------------------------
o Mo (1-2exp(-t/T1 ))
N
0
-Mo
Time (t)
Figure 2.10: T1 relaxation after a 180' pulse occurs as shown here. Once again, Mo
represents the magnitude of the net magnetization M at equilibrium (before any
excitation has taken place, or after the decay processes have been long completed).
First applying a 1800 pulse, waiting a time r, and then applying a 90' pulse can
identify specific points along this curve. The transverse magnetization after the second
pulse will reflect the T1 relaxation that occurred during time r. After collecting several
points by choosing different values of t, a curve fit to an equation of the form of Equation
2.17 will give a value for T1.
2.3.4 Contrast Agents
Contrast agents (so called because they can affect the contrast in MRI images)
work by providing an extra source of magnetically active elements in solution so that
relaxation can proceed faster. As the concentration of the contrast agent increases, the
time constants decrease - relaxation happens faster. In general, the effect of contrast
agent C on relaxation time constant T (the effect is applicable to both T1 and T2) is
described by Equation 2.18 [84].
R[C]= 1 1
Tc To
Equation 2.18
where
Tc - value of the relaxation time constant in the presence of C.
To a standard value of the relaxation time constant.
R relaxivity of C.
[C] - concentration of contrast agent C.
The relaxivity, R, is a value that characterizes the efficiency with which the
contrast agent increases water relaxation - decreases the time constant. It is important to
note that since a particular contrast agent can affect T1 and T2 differently, the value of R
can be different depending on the time constant in question. For a novel contrast agent, R
can be calculated simply by measuring the effect, on the time constant of interest, of
various concentrations of the contrast agent - one of those concentrations, of course, will
be 0 M, in order to provide a value for To. Having calculated the value of R from
solutions of known concentration, the concentration of C in unknown solutions can be
determined by measuring one of the time constants.
2.4 Previous Work
The use of NMR/MRI to examine cartilage has been a topic in the literature for
some time [4, 7, 29, 36, 47, 62, 39]. The non-invasive nature of MR as well as its marked
ability to effectively image soft tissues, combined with the prevalence of cartilage
diseases makes the combination quite appealing. Some of the work that has been done,
however, is of particular importance for this work, as the experiments described below
focus on particular aspects of this work.
2.4.1 Measurements with Sodium and Gadolinium
In 1992, Lesperance et al showed that NMR measurements of sodium ion
concentration could be used to track tissue fixed charge density in cartilage via the
Donnan model [47]. That paper also established that not only did sodium measurements
track cartilage FCD, but the values so calculated were closely matched by values
obtained by spectrophotometric assay methods. (Using bovine chondroitin sulfate as a
standard led to a values of FCD that were 100 + 7% of those calculated from sodium
concentration measurements.) Bashir further explored the possibilities by looking at the
implications of sodium T 1 and T2 for imaging [4]. Unfortunately, not only is sodium MR
complicated by extremely small T2s, but the amount of sodium present in organic tissues
is insufficient to provide a strong signal without repeating the scans many times for signal
averaging purposes. Further, although sodium is ubiquitous in real physiological systems,
in vivo studies using sodium MR are impractical. There is currently no means of
quantifying the results of an in vivo sodium scan because of the interrelationship between
the changing T2s and the observed sodium signal. On the other hand, if sodium
concentrations could be measured quantitatively, that same ubiquity would make sodium
measurement quite attractive despite its other problems.
Ionic contrast agent gadopentetate, Gd-DTPA-2 (Figure 2.11) [11], an FDA
approved compound, is regularly used via injection in MRI studies. As such, there was
information available on its use in other tissues [21] and its characteristics had been
explored to some extent. [22].
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Figure 2.11: A chemical structural diagram of gadopentetate (Gd-DTPA'2 ). The
zigzag line in the picture represents a temporary weak bond with a water molecule
in the neighborhood of the gadopentetate ion. By binding in this manner, the water
molecule is forced to spend more time in the vicinity of the magnetically active Gd-
DTPA 2, which increases the relaxing effect.
In 1996, Bashir et al used measures of Gd-DTPA-2 in cartilage and Donnan theory
to determine FCD [7]. They showed that, as with calculations using Na and calculations
using Gd-DTPA -2 resulted in values of FCD that correlated very nicely (r2=0.94).
2.4.2 Effects of Particular Interest
Figure 2.12 is a copy of a graph published by Bashir et al. Note that the x and y
axis both represent FCD. The only difference is that along the x-axis, FCD was
calculated by measuring sodium concentration and applying the Donnan model. Along
the Y-axis, on the other hand, FCD was calculated from measurements of gadopentetate
concentration. If the Donnan model adequately describes ion distribution, then the values
calculated from the two measurements will be equal. However, this is not the case. In
fact, the gadopentetate based values are related to the sodium based values by a line with
a slope of 0.49 = V2. The goal of this work will be to examine one possible reason for this
factor of two (or factor of one-half, depending on the viewpoint).
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Figure 2.12: This data in this graph (copied with permission of the author) was
published by Bashir et al in 1996 [7]. The x-axis is FCD as calculated from
measurements of Na' concentration. The y-axis is FCD as calculated from
measurements of Gd-DTPA "2 concentration. Both measurements were taken after
equilibration in solution containing both sodium and gadopentetate. The slope of
the regression fitted line shown is 0.49. The ideal Donnan model has no explanation
for this factor of 2 difference in calculated values.
Chapter 3: Theoretical Analysis
The structure of cartilage provides one possible explanation for the factor of two
ratio noticed in Bashir's experiments [7]. As Figure 2.1 suggests, the water content of
cartilage is divided between two different regions: the intrafibrillar region, within the
collagen fibrils, and the extrafibrillar region. In fact, roughly 30% of the tissue water can
be found within the collagen fibers [51]. The important aspect of this division, however,
is the fact that, due to the networked structure of the collagen bundles, the proteoglycans
(and therefore the associated fixed charge) cannot enter the collagen fibers [55]. This
means that the two water populations, intra- and extra- fibrillar, have different local fixed
charge densities. Although the relationships outlined by Equation 2.1, Equation 2.2, and
Equation 2.3 hold for each of the two regions, if compartmentalization is a factor, the
relationships cannot be applied to the overall bulk of a cartilage sample.
The NMR methods developed by Lesperance et al [47] and Bashir et al [7],
however, do not differentiate between the two water compartments. The values for
sodium concentration and gadopentetate concentration calculated from NMR
measurements reflect the volume averaged concentrations from each compartment.
C , = C IF, VIF + C EF, VEF
Equation 3.1
where
CM,- volume averaged concentration of species i (measureable)
VIF volume fraction of water in intrafibrillar space.
CIF, concentration of species i in intrafibrillar space.
VEF - volume fraction of water in extrafibrillar space.
CEF, concentration of species i in extrafibrillar space.
Since VIF and VEF are volume fractions, the following relation must hold true:
VIF + VEF = 1
Equation 3.2
Further, since the intrafibrillar space is charge free, at equilibrium, the
concentrations of all ions within must be equal to the concentrations in the external
solution. Only the concentrations of ions in the extrafibrillar space are affected by the
fixed charge. In keeping with the notation introduced with Equation 2.1:
*.VIF 1-VEF
CIF, =Ci
CEF- i
Equation 3.1 can now be restated.
CM , C, -vEF)+ iCEF
Equation 3.3
3.1 Gd-DTPA "2 Based Calculations
Equation 3.3 provides the means to determine whether it is worthwhile to
continue with this avenue of exploration. Spreadsheet based manipulations can provide
an idea as to whether or not the partitioning of tissue water into two compartments has a
significant effect on the ratio of FCD as calculated from measurements of Na and Gd-
DTPA-2 . Since measured concentrations are, in fact, the volume averaged concentrations
of ions in the two compartments that compose cartilage, the fixed charge densities
calculated using these measurements and the Donnan single compartment model must
reflect the nature of the volume averaging. In fact, it is expected that FCD calculated
from different ions will reflect volume averaging differently. Choosing a value to be the
FCD as determined from Na+, and working backward using Equation 2.1, Equation 2.2,
Equation 2.3 and Equation 3.3, a value for FCD as it would be calculated from Gd-
DTPA-2 can be derived. (This derivation is outlined in Appendix A.) Figure 3.1 plots the
ratio of the two FCDs as a function of volume fraction of the extrafibrillar compartment,
showing the effect of the presence of two compartments on calculations of FCD using a
single compartment Donnan model and measurements of Gd-DTPA-2 and Na
concentrations.
All the curves in the figure have a non-zero slope. The ratio of FCDs does
depend on the volume of the extrafibrillar compartment in this simulation, which makes it
possible that the ratio observed by Bashir et al [7] can be explained as due to the
existence of two distinct water populations within cartilage. Further, healthy cartilage is
composed of roughly 60mg/ml chondroitin sulfate and has a fixed charge density
between -200 and -300mM. In this range, a ratio of 0.5 between FCD from Gd-DTPA-2
and Na occurs for an extrafibrillar water content between 60 and 70%.
Table 3.1 contains data collected by Bashir. In the first four columns, the
measured concentrations of sodium and gadopentetate in several samples under various
bath conditions are marked down. Given these concentrations, FCD is calculated under
the assumption that cartilage is a homogenous single compartment. As expected, the two
values of FCD are unequal. Most of these data points appear in Figure 2.12 which
shows the slope of the regression relationship between FCD calculated from Na and
FCD calculated from Gd-DTPA-2 as being equal to about 0.5. The last column of Table
3.1 contains values for the volume of extrafibrillar water needed in order for a two
compartment model to correctly explain the measured values. As shown in Appendix B,
given the assumptions behind Equation 3.3, it is possible to derive the extrafibrillar
compartment volume fraction from measured tissue ion concentrations and known bath
concentrations. Only one such volume will permit Donnan equilibrium to hold.
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Figure 3.1: Values for FCD as calculated from sodium are chosen. Each value is
then used to determine FCD as it would be calculated from gadopentetate, and the
ratio of the two numbers is taken. This value is plotted versus the volume fraction
of the total cartilage water content that is found within the extrafibrillar space. It
was also assumed, plotting these curves, that bath concentrations of Na and Gd-
DTPA"2 were 150mM and 1mM respectively. Note that none of these curves are
horizontal lines, showing that this ratio is, indeed, dependent on the volume of the
extrafibrillar compartment. Further, all curves meet when 100% of the volume is
extrafibrillar. At that point, an ideal single compartment exists. Although not
shown here, the curve generated for an FCD of -300mM shows a ratio of 0.51 at
70% extrafibrillar water.
2 2
[Gd-DTPA 2] [Na ] in
in Bath Tissue
C1
C2
C3
C4
C5
C6
C7
C8
150.0
150.0
150.0
150.0
150.0
150.0
150.0
150.0
150.4
150.4
150.4
150.4
150.4
150.4
150.4
150.4
150.4
150.4
150.4
150.4
150.4
150.4
150.4
[Gd-DTPA2 ]
in Tissue
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
0.500
0.500
0.500
0.500
0.500
1.000
1.000
1.000
1.000
1.000
2.000
2.000
2.000
2.000
2.000
FCD
from
[Na1]
271.1
298.4
285.5
331.0
328.1
326.8
382.7
327.5
325.0
345.0
393.3
417.8
449.3
323.4
340.3
390.2
418.9
424.8
328.7
345.7
384.4
405.3
431.0
FCD from
[Gd-DTPA 2]
0.550
0.470
0.480
0.420
0.420
0.420
0.330
0.440
0.168
0.178
0.122
0.120
0.125
0.348
0.312
0.271
0.269
0.241
0.825
0.733
0.612
0.558
0.572
Extrafibrillar
Compartment
Volume Fraction
-188.1
-223.0
-206.7
-263.0
-259.6
-257.9
-323.9
-258.8
-255.4
-279.4
-335.8
-363.7
-399.0
-253.5
-273.8
-332.2
-364.9
-371.6
-259.9
-280.2
-325.5
-349.4
-378.5
Average of Extrafibrillar Compartment Volume Fraction: 0.7425
Std. Dev. of Extrafibrillar Compartment Volume Fraction: 0.0888
Table 3.1: The data in the first four columns of this table is a collation of data
gathered by Bashir using bovine cartilage samples. Note that all concentrations are
in units of mM. Given ion concentrations in equilibrating solution as well as
measured ion concentrations in the tissue, FCDs are calculated treating the tissue as
a single homogenous compartment. As Bashir et al demonstrated [7], FCDs
calculated in this manner from measurements of [Na+] and [Gd_DTPA-2] are
unequal. The last column contains the relative volume fraction of the extrafibrillar
compartment required to force sodium and gadopentetate measurements to give the
same value for FCD in the extrafibrillar space. The average and standard deviation
of these values are presented as well. These data seem to suggest that roughly 70%
of the sample water was in the extrafibrillar space.
As can be seen, most of the samples listed here would satisfy Donnan and have a
volume averaged tissue concentration equal to the measurements if about 70% of tissue
water was extrafibrillar. In fact, as the calculations at the bottom of the table show, the
average required volume was 74%, with a standard deviation of 9%. The 70% value
Sample
Name
-91.0
-116.0
-112.6
-134.2
-134.2
-134.2
-174.9
-126.6
-172.4
-162.0
-230.5
-233.6
-225.6
-166.4
-185.4
-210.8
-212.0
-232.6
-137.6
-157.4
-188.7
-205.4
-200.7
[Na+]
in
Bath
0.535
0.623
0.624
0.664
0.666
0.667
0.750
0.638
0.796
0.742
0.860
0.849
0.820
0.780
0.813
0.825
0.810
0.843
0.677
0.727
0.781
0.805
0.782
_ _
derived here also agrees with values reported by Maroudas for valuations of water
content of the extrafibrillar space. [51].
3.2 CI' Based Calculations
Having shown that the one to two ratio observed can theoretically be described by
utilizing a two compartment model of cartilage, it was decided to determine if the same
effect would be observed for calculations of FCD using measurements of chlorine ion
concentration. The first step, once again, was to work backward from a chosen value of
FCD as calculated from Na+.
Using Equation 2.1, Equation 2.2, Equation 2.3 and Equation 3.3, the FCD as it
would be calculated from Cl measurements can be found (Appendix A). Figure 3.2 plots
the ratio of these two FCDs against the relative volume of the extrafibrillar compartment,
showing the effect of the presence of two compartments on calculations of FCD using a
single compartment Donnan model and measurements of Cl- and Na+ concentrations.
In order to examine this theoretical finding, the literature provides a source of
experimental data. In 1972, Evans and Maroudas published a paper [52] describing
research in which they made use of radiotracer methods to measure the concentrations of
Na and Cl- ions in cartilage after it was allowed to equilibrate in solutions of known
concentrations. Along with the relevant analysis, this paper included much of the raw
data that was collected. Table 3.2 tabulate part of this data in the first 5 columns. (The
first two columns simply identify the different samples.) For space reasons, several
samples that were not used for the purposes of this paper were not included in the table.
These samples were ignored for one of two reasons. In some cases, the data published
contained what appeared to be typographical errors, as the values appeared to be a factor
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Figure 3.2: Values for FCD as calculated from sodium are chosen. Each value is
then used to determine FCD as it would be calculated from chlorine, and the ratio of
the two numbers is taken. This value is plotted versus the volume fraction of the
total cartilage water content that is found within the extrafibrillar space. It was
also assumed, plotting these curves, that bath concentrations of Na + and Cl" were
150mM. Note that none of these curves are horizontal lines, showing that this ratio
is, indeed, dependent on the volume of the extrafibrillar compartment. Further, all
curves meet when 100% of the volume is extrafibrillar. At that point, an ideal single
compartment exists. Qualitatively, these curves very much resemble those shown in
Figure 3.1 for Gd-DTPA' 2
of 10 greater or less than that of similar samples. Also ignored were samples equilibrated
at bath concentrations of NaCl lower than 100 mM. Maroudas and Evans acknowledged
in their paper that at low bath concentrations, the activity coefficients of the ions in
cartilage were significantly different from the activity coefficients in the bath.
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33 1 150.0
2 150.0
3 150.0
4 150.0
5 150.0
45 1 150.0
2 150.0
3 150.0
4 150.0
5 150.0
222.0
248.0
279.0
319.0
306.0
205.0
256.0
288.0
306.0
320.0
[Cl] in
Tissue
97.1
99.0
81.0
73.1
66.5
106.0
91.0
82.6
69.4
64.6
150.0 174.0 132.0
150.0 198.0 105.0
140.0
140.0
140.0
140.0
138.0
138.0
138.0
138.0
100.0
100.0
100.0
224.0
267.0
315.0
260.0
174.0
183.0
204.0
228.0
145.0
172.0
165.0
102.0
81.5
73.5
59.5
128.0
107.0
98.9
83.4
94.4
69.0
56.9
FCD
from
[Na1
-120.6
-157.3
-198.4
-248.5
-232.5
-95.2
-168.1
-209.9
-232.5
-249.7
FCD
from
[Cl-
-134.6
-128.3
-196.8
-234.7
-271.8
-106.3
-156.3
-189.8
-254.8
-283.7
-44.7 -38.5
-84.4 -109.3
-136.5
-193.6
-252.8
-184.6
-64.6
-78.9
-110.6
-144.5
-76.0
-113.9
-104.4
-90.2
-159.0
-193.2
-269.9
-20.8
-71.0
-93.7
-144.9
-11.5
-75.9
-118.8
Extrafibrillar
Compartment
Volume Fraction
Average of Extrafibrillar Compartment Volume Fraction: 1.049
Std. Dev. of Extrafibrillar Compartment Volume Fraction: 0.910
Table 3.2: The data in the first five columns of this table is copied from data
published by Evans and Maroudas [52]. Note that all concentrations are in units of
mM. Given ion concentrations in equilibrating solution as well as measured ion
concentrations in the tissue, FCDs are calculated treating the tissue as a single
homogenous compartment. Interestingly, the calculated FCDs are sometimes fairly
close to each other, and sometimes quite far apart. The last column contains the
relative volume fraction of the extrafibrillar compartment required to force sodium
and chlorine measurements to give the same value for FCD in the extrafibrillar
space. The average and standard deviation of these values are presented as well.
The average value calculated here is actually greater than 1 (this is biased heavily by
a single sample - sample 2 from subject age 67) which is impossible. Considering
that quite a few of the individual samples also require an extrafibrillar volume
fraction greater than one in order to set FCD from Na equal to FCD from Cl',
however, it seems clear that either the two compartment model does not well suit
this data, or these data are inaccurate..
- -- - -
1.329
0.709
0.989
0.941
1.198
1.467
0.887
0.878
1.112
1.144
0.480
4.800
0.496
0.775
0.766
1.747
0.100
0.722
0.695
1.006
0.064
0.544
1.279
Since the remainder of the data presented in this work was obtained under conditions of
Donnan equilibrium, it seemed reasonable to ignore data recorded under different
conditions. Further, low bath concentrations of NaCl leads to even lower tissue
concentrations of C1- in the tissue due to the nature of the Donnan partitioning. At such
low concentrations, small errors in measurement can comprise large errors relative to the
magnitude of the overall measurement.
In columns four and five, the measured concentrations of sodium and chlorine in
several samples under various bath conditions are marked down. Given these
concentrations, FCD is calculated under the assumption that cartilage is a homogenous
single compartment. In this case, the two values of FCD are sometime quite close and
sometimes quite far apart. Figure 3.3 plots FCD as calculated from sodium vs. FCD as
calculated from chlorine in Table 3.2. As the graph shows, the slope of the regression
relationship between the two is quite close to one, which, given Figure 3.2, is unexpected.
The last column of Table 3.2 contains values for the volume of extrafibrillar water
(calculated, once again, using the relations outline in Appendix B) necessary for a two-
compartment model to correctly describe the measured values. Observe that many of the
samples require a volume fraction greater than one in order to satisfy the requirement of
equal FCDs from either measurement. Given the definition of the volume fraction
(proportion of total sample water in the extrafibrillar space), it is impossible for the value
to be greater than one.
Neither the data in Table 3.2, nor the plot in Figure 3.3 support a two-
compartment model for cartilage. On the other hand, given the large variance in
extrafibrillar volume fraction, neither do they completely exclude the possibility. Further
exploration is warranted.
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Figure 3.3: A plot of FCDs as calculated from measurements of sodium
concentration vs. FCDs as calculated from chlorine concentration. The slope of the
regression line is 1.11, fairly close to the value expected if the system was well
described as a single ideal Donnan compartment.
3.3 Na* Measurements
One last aspect of the two-compartment model that was explored on a theoretical
basis was the effect of the two compartments on the validity of FCD measurements using
Na ion concentrations. Since it has been validated by Lesperance et al that such
measurements do actually result in reasonable values of FCD in cartilage [47], this last
consideration is quite important.
FCD calculated using the Donnan single compartment model and a volume
averaged measurement of sodium ion concentration is compared to volume averaged
FCD (Figure 3.4). Data was generated by once again working backwards from a chosen
value of FCD as calculated from Na measurements. A route can be traced from sodium
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Figure 3.4: Values for FCD as calculated from sodium are chosen. Each value is
then used to determine actual FCD in the extrafibrillar compartment. From this
value, a volume averaged FCD is calculated, and its ratio to the originally chosen
value is taken. This value is plotted versus the volume fraction of the total cartilage
water content that is found within the extrafibrillar space. It was assumed, plotting
these curves, that bath concentrations of Na' 150mM. The largest differences
between volume averaged FCD and FCD from sodium measurements occurs in the
low FCD region.
based FCD to average sodium concentration to sodium concentration in
extrafibrillar space to FCD in extrafibrillar space. Since there is no fixed charge in the
intrafibrillar space, determining the volume averaged FCD is a matter of dividing by total
volume. The ratio obtained by comparing this derived value to the number with which the
process started shows the effect of having two compartments when computing FCD from
a single compartment model and measurements of Na' concentration.
The key point here is that, compared to Figure 3.1 and Figure 3.2, the curves
curves in Figure 3.4 are almost flat. Clearly, compartmental volume fractions do have an
effect on the calculated value of FCD, but the error is less that 10% at all fixed charge
densities as long as the extrafibrillar volume fraction is greater than 50%.
3.4 Hypothesis
Given the theoretical analysis above, it seemed possible that the factor of two
observed by Bashir et al [7] could, at least in part, be due to the presence of two
compartments, the intrafibrillar and the extrafibrillar, within cartilage. If this was the
correct reason, then a material consisting of only a single compartment should not show
the factor of two. More clearly, the hypothesis being tested in this work is: A true single
compartment system should show little difference between FCD as calculated from
sodium ion concentration and FCD as calculated from gadopentetate concentration
using a single compartment Donnan model.
Chapter 4: Methods
4.1 Cartilage Preparation w/Trypsin
Initially, an attempt was made to obtain a single compartment that was
intrafibrillar in nature (containing no fixed charge). In order to do this, cartilage explants
from calf ulnae were treated with trypsin to remove the proteoglycans. The remaining
collagen rich material was subjected to NMR measurements.
4.1.1 Epiphyseal Cartilage Explant
Bovine epiphyseal cartilage was obtained from distal ulnae of newborn calves.
Intact joints were obtained immediately after slaughter. The distal ulna of each joint was
exposed by cutting away surrounding muscle and tissue. The ulnar periosteum was
removed with care, the ulna separated from the radius, and then broken at the
metaphyseal/epiphyseal cartilage interface. The epiphyseal cartilage with attached bony
epiphysis was placed in Hank's solution to prevent dehydration.
Each epiphysis was then fixed in a sledge microtome and slices 1mm thick were
sectioned. The last slice on each end was discarded to ensure all the slices used were of
uniform thickness and contained no bone fragments. From each slice, 7mm diameter
cylindrical disks were cored using a dermal punch.
Each disk was then blotted dry and placed in a centrifuge tube. All tubes were
placed in the freezer until needed.
4.1.2 Trypsin Degradation
Trypsin degrades cartilage, causing loss of noncollagenous proteins and
proteoglycans from the extracellular matrix leaving behind primarily pure collagen.
Total cartilage water content is affected because the loss of proteoglycan causes a
decrease in swelling.
After one set of NMR measurements, cartilage samples were removed from the
freezer and bathed overnight in 2 ml saline containing 2.5 mg/ml trypsin. Cartilage was
then removed from the trypsin and bathed in 2 ml fetal calf serum for several hours to
halt trypsin activity. The now visibly 'gooey' samples were put in centrifuge tubes and
returned to the freezer.
4.1.3 Just Prior to NMR
All cartilage samples were removed from the freezer and equilibrated in plain
Hank's solution or in Hank's solution with an addition lmM Gd-DTPA-2 for at least 3
hours before any NMR measurements were made.
4.2 Single Compartment Model Preparation
Attempts were also made to emulate the extrafibrillar region of cartilage.
Suspensions of chondroitin sulfate were placed in dialysis bags and immersed in Hank's
solution with lmM Gd-DTPA-2. After equilibration, samples of the solutions with the
dialysis tubes were subjected to NMR measurements.
4.2.1 Charge Rich Solution
It has been shown that cartilage proteoglycan is approximately 60mg/ml water. In
order to emulate cartilage as closely as possible, a solution of 100mg/ml shark
chondroitin sulfate C (C4348 form shark, Sigma Chemical) was made up by measuring 1
g into 10 ml Hank's solution. 4 ml of the 100mg/ml solution were transferred to a
separate container, and the remaining 6ml put in the freezer. Using the 4ml put aside,
serial dilutions were made (Figure 4.1) by transferring 2ml of each solution into another
container and mixing in 2ml of additional Hank's solution. Concentrations of 50mg/ml,
25mg/ml, 12.5 mg/ml, and 6.25mg/ml were made by serial dilution. Adding only 2ml
Hank's solution to a sixth container made a concentration of Omg/ml. The frozen 6ml of
100ml/mg solution was used for similar experiments later in time.
Hank's
Solution
2 mi 2 mi 2 ml 2 ml 2 mi
2ml 2ml 2ml 2ml
100 mg/ml 50 mg/ml 25 mg/mi 12.5 mg/ml 6.25 mg/ml 0 mg/ml ([CSI
Figure 4.1: Serial dilutions for making chondroitin sulfate solutions of different
concentrations. The first 100mg/ml solution was mixed up separately.
4.2.2 Dialysis Bag Apparatus
Once the solutions of chondroitin sulfate were made, a mechanism of suspending
it in equilibration solution was necessary. To that end, cellulose dialysis membrane
(Spectra Por MWCO 1000) was used. A molecular weight cut-off (MWCO) of 1000
means that the membrane is permeable primarily to compounds under 1000 g/mol.
Larger molecules can permeate, but not to any great extent. As Figure 2.4 shows, the
molecular weight of the chondroitin sulfate disaccharide is only 459.37 g/mol. The
purchased chemical is obtained in a polymerized form, and is, therefore, at least twice as
massive and unable to diffuse through the dialysis tube. Although there is the possibility
of some loss of material due to the presence of some monomers, most of the chondroitin
sulfate will be retained.
Instructions sent from Spectra Por regarding membrane preparations were
followed exactly. Six strips approximately 7 inches long were cut. The strips were
rinsed with distilled water for some time in order to remove excess sodium azide (toxic
storage medium). A marble was placed about 1 inch from the base of each strip, and that
inch was folded over to trap the marble in a little loop of tubing. A dialysis tube closure
(Spectra Por Closures) was used to seal the loop, holding the marble in place by keeping
the loop tight. Note that if colored marbles are used, recording the different colors
provides a means for keeping track of which solution is placed in which piece of tubing.
1.6ml of one of the previously prepared (Figure 4.1) chondroitin sulfate samples
was placed in one dialysis tubing apparatus with a Pipetman micropipette. Carefully
holding the tube at the unsealed end, any air bubbles were cleared out, and another
closure applied to seal the liquid into the central region. It is important to ensure that the
second closure closes over a region containing some of the sample fluid. This ensures
that some of the fluid is forced back into the central region , increasing the hydrostatic
pressure within the tube and assuring that osmotic effects will not cause too much
dilution of the contents of the tube.
Any excess dialysis tubing extending beyond the second closure was removed,
and the tubing/closure/marble apparatus was placed into a glass beaker full of
equilibration solution (to be described). The process just described was then repeated for
the remaining five samples. Finally, a magnetic stirring bar was added to the beaker, the
beaker top (Figure 4.2) was sealed with parafilm (to prevent water loss from evaporation)
and the beaker was placed on a stirring pad in the refrigerator. It was left to equilibrate
for one week.
Glass Beaker
Tubing
Closure Stir Bar
Dialysis Tube Stir/Heat Pad
Marble
Stir Heat
Figure 4.2: Dialysis bag apparatus. Glass beaker, here depicted with only one
sample, can hold all six samples simultaneously. Each tubing apparatus floats
marble side down in the equilibration solution. The tubing closures are lighter than
water. Not only do the marbles help to weigh down each bag, but they also help to
orient each one vertically.
At the end of the week, the beaker was removed from the refrigerator and
individual bag concentrations identified (by marble color). Remove beaker from
refrigerator and identify individual bag concentrations. One sample tube was picked and
help marble-side up in order to let excess equilibration solution drip away. The closure
near the marble was carefully removed, with care taken to maintain a safe grip on the
dialysis bag. After unfolding the tubing and removing the marble, the tubing was
visually inspected to determine the height of liquid within. Scissors were used to snip the
tubing halfway across about 1/8 inch above the level of the liquid.
Through this gap was inserted the thin nose of a glass pipette attached to an
evacuated rubber bulb. As much as possible of the liquid within the tube was removed to
a labeled centrifuge tube. This process was repeated for the remaining five samples as
well. The centrifuge tubes were put into the freezer until the time came for NMR
measurements.
4.2.3 Equilibration Solution
The equilibration solution used in these experiments, both with trypsin-treated
cartilage and with the dialysis-tubing apparatus, was quite simple to make. For
measurements in the absence of contrast agent, Hank's solution (GibcoBRL), which is
148 mM in Na+ was used. For measurements with contrast agent, a 1 mM contrast agent
solution was produced by mixing 499 ml Hank's solution with 1 ml contrast agent. Two
sets of experiments were done. In one, a charged ionic contrast agent, Magnevist brand
gadopentetate dimeglumine (Gd-DTPA -2) was used. In another experiment, a non-ionic
contrast agent, ProHance - brand name - took part.
4.2.4 Just Prior to NMR
Unlike cartilage samples, which need to be equilibrated just before scanning, the
samples of chondroitin-sulfate-rich fluid need only be thawed. 50pL aliquots of each
sample were put into MR sample vials (small glass tubes with a diameter of a few
millimeters) for imaging.
4.3 NMR Measurements
The various NMR parameters need not be outlined in detail here. The procedures
followed were almost exactly as outlined by Bashir et al. The reader is referred to their
paper [7] for details on the NMR methods beyond the few items and exceptions noted
here.
All measurements were on an 8.45 Tesla Bruker spectrometer (Bruker
Instruments). Cartilage samples were first blotted dry and weighed. All samples were
then placed in a dual 10/15mm (23Na/'H) broadband probe for measurements.
T1 was measured with an inversion recovery sequence. Contrast agent relaxivity
was calculated, using Equation 2.18, from only two measurements, in the absence and in
the presence of a known concentration of contrast agent in Hank's solution. It has
already been shown that relaxivity of gadopentetate in normal and degraded cartilage is
equal to that in saline [22], so use of relaxivity measured in Hank's is justified for
calculations in cartilage and in chondroitin sulfate solutions. Although the same has not
been shown for ProHance, such was assumed to be true. T1 measurements in samples
were then also put through Equation 2.18 with the calculated relaxivity in order to
determine contrast agent concentration ([Gd-DTPA -2] and [ProHance]). Since the
chondroitin sulfate solutions at their final concentrations were available for NMR only
after equilibration, T1 in the absence of contrast agent was not measurable. The value
obtained for T1 in Hank's without contrast agent was used instead. This procedure was
validated by making T1 measurements with varying amounts of chondroitin sulfate and
no contrast agent to determine the relaxation effect of the chondroitin sulfate.
Sodium spectra were obtained by a one pulse sequence with 2000 averages.
Sodium content was determined from sodium spectra by calibration to a set of standards
- solutions of known sodium concentrations.
Proton spectra were also obtained by a one pulse sequence. Water content was
similarly calculated from proton spectra by calibration to a set of standards. (Although
there are protons within all the samples that are not part of water, since an overwhelming
majority of the protons are from water, the contribution of those other protons is assumed
to be inconsequential.) Note that, for the cartilage trypsinization experiments, water
content of cartilage prior to trypsinization was calculated as 70% of the wet weight,
assuming that about 70% of cartilage mass was composed of water which has a density of
ig/ml.
Given water content from proton spectra and sodium content from sodium
spectra, sodium concentrations were easily calculated.
FCDs were calculated with Equation 2.7 using the concentrations evaluated above
where possible. Note that measurements of ProHance did not give FCD, as a non-ionic
agent theoretically does not distribute in a manner dependent on FCD.
4.4 Spectrophotometric Assay
After NMR measurements were completed, all dialyzed samples were analyzed
for CS content by using the dimethylmethylene blue (DMB) assay [24]. Absorbances
were obtained at 525nm with a Lambda 3B spectrophotometer (Perkin-Elmer).
Conversion to concentrations was done by comparison to standards generated from the
same chondroitin sulfate used for the original samples. In previous work, it had been
observed that choice of standard could affect the outcome of the assay [47]. In this case,
since both samples and standards come from the same source, the concentrations
obtained by these comparisons to standards should reflect the actual composition of the
samples. Since the DMB standard concentrations range from 0 to 1000 gg/ml, it was
usually necessary to dilute samples 1:10 or 1:100 since sample concentrations were in the
mg/ml range. (Of course, no dilution was needed for the 0 mg/ml sample.)
Calculation of FCD from the concentrations found through the DMB assay was
based on two assumptions. First, the molecular mass of CS was assumed to be
503.34g/mol as calculated from the chemical structure in Figure 2.4 and taking into
account that the purchased chemical was a sodium salt (two sodium atoms per
disaccharide). Second the charge on each monomer was assumed to be -2. FCD was
then calculated by dividing the concentration (mg/ml) by the molar mass (g/mol),
multiplying by -2 (-2 units charge per monomer) and multiplying by 1000 to find FCD in
mM rather than in M units.
The presence of gadopentetate in samples being analyzed with the DMB assay
was a concern. Chemical interaction between the anionic gadopentetate and the cationic
components of DMB could have affected the assay result. An experiment was done to
test whether a reaction occurred. 4ml of 1075p.g/ml CS were made by weighing 4300pg
of CS into 4ml Hank's solution. Iml of 50mM Gd-DTPA-2 was made by mixing 0.9ml
Hank's solution with 0.lml 500mM Gd-DTPA2 . Serial dilutions (Figure 4.3) were made
as shown. 500 pl of each dilution were mixed with 500 .l of the prepared 1075pg/ml CS
solution.
Hank's
Solution
0.6 ml 0.9 ml 0.9 mi 0.9 ml 1.0 mi
50 mM 20 mM 2 mM 0.2 mM 0.02 mM 0 mM +-[Gd-DTPA-2]
Figure 4.3: Serial dilutions for making Gd-DTPA"2 solutions of different
concentrations. The first 50mM solution was mixed up separately.
The final solutions all contained 537.5gg/ml of CS and were between 25 mM and
0.01 mM in Gd-DTPA-2. These solutions were then assayed with the DMB assay, and
CS concentration calculated based on those measurements. The standards for the DMB
assay were generated using 500 pl of the same 1075pg/ml CS solution.
Chapter 5: Results & Discussion
This section will present results mainly from three different experiments, with
supporting experimental results occasionally provided.
5.1 Cartilage Measurement
The first attempt at generating a single compartment - this one with no fixed
charge - was made by degrading cartilage with trypsin. Table 5.1 tabulates the FCDs
calculated from ion concentration data collected before and after trypsin degradation.
Calculated FCDs (M)
Before Trypsin After Trypsin
Sample FCD from FCD from Ratio of FCD from FCD from Ratio of
[Nal [Gd-DTPA-2 ] FCDs [Na ] [Gd-DTPA 2] FCDs
A2 -0.331 -0.158 0.478 -0.006 -0.022 3.515
A3 -0.367 -0.180 0.492 0.075 -0.011 -0.149
B2 -0.330 -0.127 0.385 0.020 0.001 0.058
B3 -0.336 -0.148 0.441 0.028 -0.010 -0.376
B4 -0.412 -0.180 0.438 0.017 0.001 0.046
..7 Average: 0.447
Std. Dev.: 0.042
Table 5.1: Shown here are the FCDs, in moles/liter (M) of five cartilage samples
both before and after treatment with trypsin. Before the treatment, as expected
form the results of Bashir et al [7], the average of the ratio between FCDs calculated
from Na+ and from Gd-DTPA2 is equal to 0.447 and is within one standard
deviation of 0.5. After treatment, no attempt was made to evaluate the ratio. The
calculated fixed charge densities were, for many of the samples, actually positive
values, which clearly indicates difficulties with measurement.
As the table shows, the FCDs calculated from ion concentrations measurements
collected before treatment with trypsin follow the established pattern - the ratio of FCDs
calculated using measurements of the two different ions is almost equal to 1/2. After
treatment with trypsin, however, no attempt was made to generate an average. The
calculated FCDs are, for some of the samples, actually positive values, which is
impossible. Theoretically, with the loss of the charged proteoglycans, the concentrations
of ions within the tissue should equal the concentrations of ions in the bath. Equation
2.7, which is used to calculate fixed charge density from ion measurements, is quite
sensitive to minor changes in tissue ion concentration when tissue concentrations are
equal to or less than bath concentrations. Small errors in measuring gadopentetate
concentration, therefore, are reflected as large errors in the FCDs calculated. FCDs
calculated from sodium are still more likely to incorporate error as NMR measurements
of sodium in degraded cartilage suffer from visibility problems. Loss of proteoglycan
from the cartilage matrix has the effect of lowering T2. The loss of signal detection time
makes it much harder to detect, with an NMR measurement, all the sodium that is
present. Measurements that indicate tissue concentrations less than bath concentrations
of sodium ions are probably due to this effect. Such measurements would lead to positive
values calculated for FCD.
Note, however, that examination of Gd-DTPA-2 concentrations inside and outside
the tissue shows them to be very similar. In Table 5.2, these concentrations, along with
Examination of [Gd-DTPA- ] after Trypsin
Absolute Value of
Sample [Gd-DTPA] [Gd-DTPA2] Tissue [Gd-DTPA -2]-in Bath in Tissue
Bath [Gd-DTPA2 ]
A2 1.00E-03 8.63E-04 1.37E-04
A3 1.00E-03 9.28E-04 7.19E-05
B2 1.00E-03 1.01E-03 7.63E-06
B3 1.00E-03 9.33E-04 6.72E-05
B4 1.00E-03 1.01 E-03 5.31 E-06
Average: 5.77E-05
Std. Dev.: 5.43E-05
Table 5.2: Gadopentetate concentration in the five cartilage samples after
degradation by trypsin was calculated from T1 measurements. The difference
between tissue and bath concentrations is shown here in the last column. Note that
the average difference, while not actually equal to zero, is more than an order of
magnitude smaller than the concentrations involved.
the absolute value of the difference in concentration, are tabulated. The lack of a
significant difference suggests that the interior of the collagen fibers, which makes up a
larger portion of the total sample volume after removal of the proteoglycans, is accessible
to the contrast agent.
5.2 Single Compartment Measurements
Having shown that gadopentetate appears to be distributed both inside and outside
the collagen fibrils, attention was shifted to a proteoglycan only compartment. Since
proteoglycans have no structural integrity, an imitation of the proteoglycan compartment
was constructed as described in the methods (Section 4.2).
The concentrations of sodium and gadopentetate in the chondroitin sulfate
solutions as determined from NMR measurements where used to calculate fixed charge
density as outlined in section 4.3. After the NMR measurements were completed, a
DMB assay was done to determine the actual amount of chondroitin sulfate present in
each sample solution. FCD was determined from this biochemical data as described in
section 4.4.
FCDs calculated by each of the three methods (from Na , from Gd-DTPA2 , and
from the DMB assay) are plotted against each other in Figure 5.1 and Figure 5.2. Figure
5.1 shows a plot of FCD from sodium measurements against FCD from gadopentetate
measurements. In the absence of collagen, there is no second charge free compartment to
cause deviations from the ideal Donnan system. Therefore, the slope of the regression
line on this plot was expected to equal one, as predicted by Equation 2.7. As is
immediately clear, the slope of the plotted relationship, 0.468, is nowhere near one, but
quite close to 0.5. The factor of 2 seen in Figure 2.1, thought to exist because of water
compartmentalization, continues to exist in a single compartment imitation of cartilage.
The hypothesis stated in section 3.4 appears to have been disproved by this result.
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Figure 5.1: Plot of FCD as calculated from measurements of Na + concentration
against FCD as calculated from measurements of Gd-DTPA'2 concentration. The
data leading to these values of FCD were from NMR measurements of chondroitin
sulfate solution that had been equilibrated in Hank's solution with Gd-DTPA'2.
Since there was no collagen present, the solution in dialysis bag construct should
have been an ideal single compartment. Yet the regression line slope for these data
is approximately 0.468 rather than the expected value of one.
The appearance of Figure 5.2 was a puzzle. Plotting FCD as calculated from
sodium against FCD as calculated via biochemical methods yielded an unexpected result.
The slope of the regression line between the two sets of data points is very close to 1/2.
These two graphs posed interesting questions. Figure 5.1 appeared to clearly invalidate
the original hypothesis. Yet the figures which follow immediately after suggest that
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Figure 5.2: This graph plots FCD as calculated from measurements of Na+
concentration against FCD as calculated from measurements of CS concentration
via DMB. Unexpectedly, the slope of the regression curve here is 0.515. There is an
apparent factor of two ratio between FCD from sodium and FCD from DMB. This
lead to verification the Gd-DTPA-2 does not affect the DMB assay (Table 5.3).
Ultimately, repetition of this particular comparison using data from other
experiments refuted the suggestion that a factor of two ratio actually exists.
something odd has occurred. It has been shown that in cartilage, FCD as calculated from
sodium measurements does correctly predict the fixed charge density [47]. The last
figure seemed to suggest that this may not hold true for simple chondroitin sulfate
solutions. Since, as noted previously, the chondroitin sulfate used for the DMB assay
standards comes from the same source as the CS in the samples, there is little chance of
hidden Error! Bookmark not defined, in the assay procedure. Calculation of FCD from
the concentration of CS so calculated is a very simple and routine process, again leaving
little room for a hidden error. The only obvious possibility as a source of error was the
inclusion of gadopentetate in the solutions assayed using DMB. Any chemical reactions
between the cationic dye and the anionic gadopentetate could affect the final result.
Samples in Various Gd-DTPA-2 Concentrations
[Gd-DTPA 2 ] (mM) 25 10.00 1 0.1 0.01 0 S
t
Actual [CS] (gg/ml) 537.5 537.5 537.5 537.5 537.5 537.5 A DA D
[CS] from DMB (lg/ml) 581.2 573.6 570.3 584.5 563.8 575.8 v ee v
DMB [CS] / Actual [CS] 1.08 1.07 1.06 1.09 1.05 1.07 1.07 0.01
Table 5.3: Ratio of CS concentration measured via DMB to actual CS concentration.
Although the [CS] calculated from DMB is at least 5% greater than the known [CS]
of each sample, note that the same holds true for the OmM [Gd-DTPA"2] solution.
This means that the 5% difference is likely to be measurement or calculation error,
having no significance as far as the effect of gadopentetate upon the DMB assay. In
fact the standard deviation for these samples is only 1%.
At first glance, Table 5.3 appears to show that there is some interaction between
gadopentetate and the DMB. All the concentration calculated from measurement are at
least 5% greater than the known concentrations. The OmM gadopentetate solution also
shows this shows the same results, however, suggesting that the observed difference is
due to measurement or standardization error, rather than to any effect of the
gadopentetate. Therefore, the gadopentetate does not appear to have an effect on the
DMB measurements. (Even if some interaction is hidden within that 5% region, the
results depicted in Figure 5.2 would require effects on the order of 50%.)
Since the factor of two relationship observed between FCD calculated from
sodium and FCD calculated from the DMB assay did not seem to be a result of the DMB
assay, the only avenue left for error was the NMR measurement process. The experiment
was, therefore, repeated, and the results are plotted in Figure 5.3 and Figure 5.4.
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Figure 5.3: Another plot of FCD as calculated from measurements of Na'
concentration against FCD as calculated from measurements of Gd-DTPA-2
concentration. The data leading to these values of FCD were from a second set of
NMR measurements of chondroitin sulfate solution that had been equilibrated in
Hank's solution with Gd-DTPA"2 . The regression line slope for these data is
approximately 0.5181. The factor of two relationship here remains as in the
previous experiment.
As before, the slope of the regression line between FCD calculated from
measurements of sodium concentration and measurements of gadopentetate concentration
are related by a factor of two. Once again, the hypothesis has been disproved.
y = 0 5181x+ 6.6985
R2 = 0 8968
0
0.
-140
I I I I I I
The line relating FCD from sodium measurements to FCD from the DMB assay,
however, now has a different slope, 1.0962, much closer to one than its former 0.5821.
This suggests that at least one of the two measurements is the result of an error. Further
data would be useful to determine which is more likely to be correct.
FCD from Na+ vs. FCD from
OD -20.0
DMB Assay
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Figure 5.4: A second plot of FCD from sodium measurements against FCD from the
DMB assay. Unlike the last time (Figure 5.2), the slope of the regression line is
approximately equal to one, providing support for the idea that the previous set of
measurements was somehow skewed by a factor of two during the experiment.
y = 1 D962x+ 13.788
R2 = 0 9711
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5.3 Steric Effect Measurement
From Figure 5.1 and Figure 5.3, it appeared clear that the factor of two observed
by Bashir et al was not due primarily to regions with different fixed charge. The
possibility existed, however, that steric exclusion might be causing the formation of two
regions of differing ion concentration. The gadopentetate molecule, as shown in Figure
2.11, is a large organometallic complex. The sodium ion, on the other hand, is a single
atom (MW = 23.0g/mol). It is conceivable that there might exist regions accessible to the
small sodium ion but inaccessible to a large complex.
To test this hypothesis, the chondroitin sulfate solution dialysis experiments were
repeated two more times. This time, however, a non-ionic gadolinium based contrast
agent (ProHance - Gd-HP-DO3A) was used instead of Gd-DTPA 2. ProHance, like
gadopentetate, is a fairly large organometallic coordination compound. Obviously, there
is no expected correlation between the existence of fixed charge and ProHance
concentration. ProHance concentration in all samples, regardless of CS concentration,
should be the same as in the bath. If steric exclusion is a factor, however, then ProHance
concentration in samples should decrease with increasing CS concentration.
In Figure 5.5, the concentrations of Na+ and ProHance found in the samples is
normalized with respect to bath concentrations and plotted. Concentrations of Na show
a clear correlation with fixed charge density. The negative increase of FCD implies a
greater concentration of sodium. ProHance concentrations, at low FCDs, are almost the
same in the samples and in the bath. Further, the values stay fairly constant over small
changes in FCD. At higher FCDs, however, the ProHance in the samples apparently
increases, acting somewhat like a positive ion. Although only one set of data is presented
here, both of the experiments using ProHance displayed this apparent concentration
increase in samples at higher FCDs. Steric exclusion, as explained before, would result
not in an increase in average concentration, but rather in a decrease.
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Figure 5.5: This figure shows concentrations of sodium and ProHance in the dialysis
bags normalized to concentrations outside. As expected from Donnan
considerations, the concentration of sodium inside increases with respect to the
outside as fixed charge density increases. At low FCDs, [ProHance] behaves exactly
like a non-ionic material is expected to behave under Donnan equilibrium: the
normalized concentration is about equal to 1, and is fairly constant with fixed
charge density. At higher FCDs, however, the ProHance concentration actually
appears to increases in the sample. (Steric exclusion would suggest a decrease.) The
"Disassociation Compensated" curve on the graph represents an attempt at
explaining the apparent increase in sample [ProHance]. Disassociated Gd+3 could
significantly alter the Tls used to calculate [ProHance]. The curve represents
[ProHance] corrected for a 1% disassociation.
_-._- [Na+] Normalized to Bath [Na+]
- -- - [ProHance] Normalized to Bath [Prohance]
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One possible explanation for the apparent increase was the link between T1 and
ProHance concentration. Since the value actually measured is TI, any other element
which alters T1 would alter the calculated values of ProHance concentration. If the
ProHance metal complex is partially disassociated, permitting some free Gd+3 ions in the
bath, there would be a T1 effect associated with the free metal rather than with ProHance.
Further the cationic nature of Gd+3 would cause concentrations in the samples to increase
with the negatively increasing FCD.
Theoretically, it is possible to solve, using Donnan, for the concentration of Gd +3
in each sample if the bath concentration of the ion is known.
cNa+ CGd+3
CNa+ J CGd+3
CGd+3 = CGd+3 C a
cNa+
Given this solution, assuming that the Gd+3 ion has the same relaxivity as
ProHance, and assuming that ProHance undergoes 1% spontaneous disassociation, the
observed curve can be redrawn in Figure 5.5 after compensating for the presence of Gd+3
As can be seen in the figure, the line formed by the compensated points does not turn
upward as sharply as that formed by the uncompensated figures. Complete correction is
unlikely to be observed, even if this were the correct explanation, due to the two
assumptions made above. (The relaxivity of free Gd+ 3 in water has, in fact, been shown
to be about three times the relaxivity of ProHance at 20MHz [73,45,28], which suggests
that only a third as much disassociation is needed to achieve the error observed.
Unfortunately, it is not possible to incorporate this information in plotting the
compensated curve since, if disassociation occurs, the relaxivity calculated for ProHance
already incorporates the contribution of some free Gd +3 . This leads to more unknowns -
concentrations inside tissue and their relationships - than there are equations to describe
the system.)
Since the data from this second set of experiments (using a non-ionic agent)
partially repeated the data from the experiments with gadopentetate, Figure 5.6 and
Figure 5.7 were generated to aid with the puzzle posed by Figure 5.2.
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Figure 5.6: This graph plots FCD as calculated from measurements of Na*
concentration against FCD as calculated from measurements of CS concentration
via DMB. The observed slope of the regression line here is 1.09, very close to 1.
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Figure 5.7: This graph, representing a fourth experiment, also depicts FCD from
sodium against FCD from the DMB assay. Here, although there is a greater spread
of the points, the slope of the line is again near one (1), at 0.90.
Unlike Figure 5.2, which plotted exactly the same variables for the experiment
with gadopentetate, the slope of the regression curves in these new figures are about
equal to 1. The only purposeful difference between the two experiments was the
substitution of ProHance for gadopentetate. This substitution offers no immediate
explanation for the problem that Figure 5.2 poses. Considering that repetition of the
experiment with gadopentetate (Figure 5.4) also led to a similar curve with a slope of
about one, the simplest explanation suggests that a procedural experimental error scaled
all values by a factor of two and that - as illustrated by Figure 5.4, Figure 5.6 and Figure
5.7 - there is a close correspondence between FCD determined from sodium
concentration measurements and FCD determined by the biochemical DMB assay.
Chapter 6: Conclusion
6.1 Summary
Experimental work published by Lesperance et al. [47] demonstrated that
cartilage fixed charge could be monitored in vitro by NMR measurements of sodium ion
signal within the tissue. Bashir et al. [7] continued with this work to show that use of a
charged contrast agent, gadopentetate (Gd-DTPA-2), and measurements of proton Ti
provided another route to the same end.
Both methods made use of Donnan equilibrium theory to evaluate fixed charge.
Interestingly, the final value of fixed charge calculated from sodium measurements was
generally twice the value calculated from gadopentetate measurements. The model in use
at the time provided no explanation for this discrepancy.
It had long been known that the water content of cartilage was divided between
two physiologically distinct regions [51]: the intrafibrillar region within each collagen
fibril, and the extrafibrillar region, which contains all the tissue fixed charge. One
possible theoretical explanation for the observed discrepancy in calculations of fixed
charge, therefore, suggested that the model used in Donnan calculations be modified to
consist of two compartments, in which all the tissue fixed charge is located in one
compartment.
Explorations of this model (section 3.1) did account neatly for the discrepancy.
If the theoretical explanation was an accurate description of the situation within
cartilage, then it was hypothesized that either one of the two compartments, if isolated
and submitted to the same sorts of NMR measurements, would show no discrepancy
between the calculated values of FCD.
To this end, an attempt was first made to examine the intrafibrillar compartment
by working with cartilage exposed to trypsin. Unfortunately, although the results of the
experiment did suggest that gadopentetate was entering the GAG free cartilage
completely, problems with low sodium visibility at low fixed charge densities made the
experiment impractical.
The extrafibrillar compartment, though not directly isolatable, was imitated by
solutions of chondroitin sulfate. Measurements were successfully made on samples with
varying fixed charge. When tissue fixed charge density was calculated from these
measurements, a discrepancy was once again observed. Calculations of FCD in single
compartment chondroitin sulfate solutions using measurements of gadopentetate
concentration yielded values about 50% less than similar calculations based on sodium
concentration measurements or on biochemical assays. The hypothesis had failed.
Further explorations were done to determine if steric exclusion effects could
provide an explanation. To this end, measurements were made using an uncharged
contrast agent (ProHance). In an ideal Donnan single compartment, any uncharged agent
would be unaffected by fixed charge. It would diffuse until concentrations within the
sample equaled concentration outside the sample. Steric exclusion, however, would
mean that the average concentration of ProHance would decrease as the excluded volume
increased. It was observed that for low fixed charges, ProHance behaved exactly as
expected, diffusing until reaching bath concentrations within the sample. For higher
fixed charge densities, however, the amount of ProHance in the sample was seen to
increase. One possible explanation, supported by theoretical analysis, is that the
ProHance organometallic complex was partially disassociated, freeing gadolinium(3+) to
affect the measurements.
6.2 Future Work
Since this work has shown that the proposed hypothesis failed, a reason for the
factor of two discrepancy which motivated this work remains to be found. Not only must
it be explained within cartilage, but also within simpler models like the chondroitin
sulfate suspensions developed here. Possibilities include:
(a) that the gadopentetate contrast agent, because of its large size and
complicated organomettalic structure allowing shielding of charge, could be
better described as behaving like a molecule with a -1 rather than a -2 charge.
(b) that a small fraction of the gadolinium is disassociated from the gadopentetate
complex, leading to free Gd+3 ions in the solution.
(c) that Donnan theory is inadequate to describe the average concentration of a
divalent ion in a charged matrix as the Donnan model neglects the complex
spatial distribution of the mobile ions..
In the light of these ideas, it would be particularly useful, from a basic science
perspective, to explore the distribution of other mono- and di- valent ions (both anions
and cations) in simple Donnan single compartment solutions. If shielding is a factor, then
less complex ions should result in measurements that do match with Donnan theory.
Exploration of Donnan single compartment models other than chondroitin sulfate
solutions could provide an avenue of research. Gels or solutions with a positive rather
than a negative fixed charge will lead to new insight into ion distribution behavior in
cartilage.
Further, since cartilage is physiologically composed of two different regions, it
remains to be determined what effect compartmentalization does have upon ion
distribution in tissue. As mentioned before, it has been shown that cartilage fixed charge
density is well described by measurements using sodium NMR. Yet, given the
compartmentalization of the tissue, there must be some error associated with these
measurements. A quantification of that error as a function of measured fixed charge
would be useful, permitting empirical calculation of true fixed charge density from the
sodium NMR based values.
On a larger screen, gadopentetate studies are already being explored as a means of
monitoring proteoglycan loss in vivo. Better understanding of the diffusion and clearance
of contrast agents from the body is needed. Development and exploration of other
charged contrast agents for use in a similar manner would be useful as well.
The potential for early diagnosis provided by gadopentetate based methods
currently being developed could soon permit a better understanding of disease onset, and
permit the development of early treatments. Hopefully, a few years from now, MRI
examination of cartilage condition will become a regular part of the yearly checkup. The
potential savings in money and in pain are huge.
Appendix A: Example of 2 Compartment FCD Derivation
Figure 3.1 and Figure 3.2 attempt to convey how the ratio between FCD
calculated from Gd-DTPA-2 (FCD calculated from C1- concentration in the case of Figure
3.2) and FCD calculated from Na concentration would be affected by extrafibrillar
compartment volume. The curves on the figures were derived assuming that although a
single compartment Donnan model is used for FCD calculations, the appropriate
description of the system is a two-compartment model.
In this appendix, the mathematical procedure used to derive each point on the
curve will be demonstrated via a specific example. Since the process is almost identical
for both gadopentetate and chlorine, the example will cover only the gadopentetate case.
First, we choose some useful bath concentrations, an initial "calculated" FCD, and
an extrafibrillar volume fraction of interest. Suppose:
vEF = 0.50
CNa+ = 150 mM
ccr = 150 mM
FCDNa = FCD from CM = -200 mM
Beginning with the assumed value for the FCD, the volume-averaged
concentration of Na+ is calculated using Equation 2.7.
2
FCD- cNa+
CM MNa+
Na+
S + (FCD)- = 0
MNa+ CMNa+ - Na+
- FCD ± (FCD)2 + 4C2NNa +
MNa+ 2
Substituting the values suggested above, the volume-averaged concentration of
Na is found to be 280.28 mM. Next, substitution into Equation 3.3 permits
determination of the actual concentration of Na in the extrafibrillar compartment.
CM a+ = CNa+ (1- F )+ CNa + VEF
CNa + VEF = CMNa+ -CNa + (1- VEF)
SNa+ - CNa+ (1- EF)
Na+ VEF
VEF
Once again substituting values shows that the actual concentration of sodium in
the extrafibrillar volume is 410.56 mM. Now, the Donnan equilibrium, as outlined in
Equation 2.4, leads to concentration of Gd-DTPA-2 in the extrafibrillar compartment.
CNa+ CGd-DTPA
- 2
CNa+ CGd-DTPA
- 2
2
2= CNa+
CGd-DTPA-2 C Na+ CGd-DTPA-2
Substitution leads to a value for extrafibrillar gadopentetate concentration: 0.13
mM. Now Equation 3.3 comes into play once more to determine the volume averaged
gadopentetate concentration.
cM =Ccd.DTPA_2(1F)+Cd.DTPA-2VE
Gd-DTP 
=  Gd-DTPA-2 EF Gd-DTPA2 EF
Recalling the chosen value of VEF, 0.50, from above, and substituting the
gadopentetate concentration calculated previously, the volume-averaged concentration is
found to be 0.57 mM. Finally, using Equation 2.7, FCD is calculated from the volume
averaged gadopentetate concentration.
FCD A2 = FCD from cM = CNa+ 2 Gd-DTPA2
Gd-DTPA- MG-DTPA2 Na+
Gd-DTPA MGd-DTPA-2
A last substitution gives shows that, as calculated from a volume-averaged Gd-
DTPA-2 concentration, the FCD is only -86.33 mM. The ratio plotted in Figure 3.1 is the
ratio of this value to the originally chosen value: (-86.33)/(-200) = 0.43.
In concluding, it is important to note that this derivation could also have been
done by choosing a volume averaged fixed charge density, determining the FCD in the
extrafibrillar compartment, and continuing on to determine the volume averaged
concentrations of sodium and gadopentetate. Once those values are known, FCD could
be calculated separately for the two ions, and the same ratio obtained. It was decided to
take the approach actually outlined in example above for several reasons. First of all,
exactly the same curves can be generated with both processes by choosing the initial
value of FCD appropriately. Given that the same curves are generated, it seemed more
practical to select the derivation method that involved fewer steps and corresponds more
closely to the types of observations actually presented in this work (fixed charge densities
calculated from volume averaged ion measurements). Finally, the issue of the
relationship between the volume averaged fixed charge density and the fixed charge
density calculated from volume averaged ion concentrations is dealt with separately by in
section 3.3.
Appendix B: Calculation of Extrafibrillar Volume
Equation 2.1 and Equation 3.3 expressed for particular ions, together provide a
system of equations that can be solved to derive an expression for the volume fraction of
water, VEF, in the extrafibrillar compartment of cartilage in terms of known or measurable
ion concentrations. Below, this derivation will be performed to express vEF in terms of
Na' and C1- concentrations, as well as in terms of Na and Gd-DTPA-2 concentrations.
The derivations below assume a couple of points. First, it is assumed that each of
the two compartments (extrafibrillar and intrafibrillar) satisfy the Donnan model at
equilibrium. This means that concentrations of ions in the intrafibrillar regime (where no
fixed charge exists) will be equal to concentrations of ions in the external bath. Ion
concentrations in the extrafibrillar region are assumed to be well described by Equation
2.1. Second, it is assumed that the external bathing solution has equal concentrations of
Na and C1-. It is possible to perform the derivation assuming different concentrations
but it is not nearly as neat or easy to follow.
B.1. Na and CI
First of all, the specific parameters which are known must be identified. When
considering a sodium and chloride system:
CM - average concentration of Na' : determined from measurement.
CM average concentration of Cl- : determined from measurement.Cr-
Co - concentration of Na' and C1- in the external solution.
Substituting as appropriate into Equation 2.1 and Equation 3.3, the following
initial relationships are found:
CM a+ = C(-VEF)CNa+VEF
Equation 6.1
CM Co -1EF)+ CC VEF
Equation 6.2
CNa_ Co
Co C-cr
Equation 6.3
Immediately, it is clear from Equation 6.3 that:
2
Co
CC1 --
C Na+
C Co VEFCOVEF
l-C Na+
2
S- CO VEF
C Na+ C MCo - Co VEF)
Now substituting a final time into Equation 6.1 leads to an equation that can be
quickly solved.
2
CM = Co(1-VEF )+ COVEF VEF
CM_ - CO u-VEF
This expression looks fairly complicated, including some second order terms, but
those terms cancel out after cross multiplication, resulting in a solution for vEF that
includes only those terms which were earlier identified as known.
Co - CN+ o- CO - CMa-
VEF -(2c -CM -C C
Equation 6.4
80
B.2. Na* and Gd-DTPA-2
A similar process can be followed for the sodium and gadopentetate system.
First, known parameters are identified:
CMNa+ average concentration of Na' : determined from measurement.
CM Gd-DTP average concentration of Gd - DTPA-2 :determined from measurement.
Co - concentration of Na' in the external solution.
CG concentration of Gd - DTPA- 2 in the external solution.
Returning to Equation 2.1 and Equation 3.3, the initial relationships are identified.
One of those relationships is expressed by Equation 6.1, as sodium is still a component.
An equivalent relationship is found for gadopentetate, the Donnan equilibrium expression
is identified and substitutions are made as appropriate.
CM Gd-DTPA-2 = CG -vEF)+ C Gd-DTPA-2 VEF
Equation 6.5
CNa _ CG
Co CGd-DTPA
- 2
Equation 6.6
Equation 6.6, once reformulated, gives:
2
C Gd-DTPA-2 Na CG
C Na+
Substituting in Equation 6.5 and attempting to solve for the concentration of Na+
results in:
C M CG -EF+ Co -EF
Gd-DTPA-2  
Na +
2
-2 Co CG VEF
CNa =- C )
C 2 - CG VEF
Gd-DTPA-
In order to avoid dealing with square roots, it makes sense to manipulate Equation
6.1 somewhat as shown:
CM Na+ coC -VEF)+ CNa+ VEF
2 Na+ iCMNa* 
-
CO 4--EF)
2
.
CNa=
VEF
Setting the two expressions for the square of Na concentration equal to each
other and manipulating the resulting equation results in an final equation of a very
familiar form.
Co CG VEF M Na
CM - CG VEF [ VEF
Gd-DTPA-2  EF
Av +BvEF +C = O
where
2A=c C. C2 G 2ccG (CMNa+ - C
B=2cocG M C OMNa+ CMGd-DTPA-2 G G MNa+ CO
c CM+ - CO 2 Gd-DTPA-2 CG
In this case, the third order terms cancelled out leaving a quadratic. The final
solutions are then easily determined by the quadratic formula. The last step is choosing
between the two possible solutions. That choice must be made to ensure that the value
calculated for VEF lies between 0 and 1 - as it represents the volume fraction of
extrafibrillar water - and is not further addressed here.
-B+ B 2-4A C
V EF
2A
Equation 6.7
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